Related Experiment Video
Updated: Aug 12, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
ACR Appropriateness Criteria® Diffuse Lung Disease: 2026 Update
, Lydia Chelala1, Christopher M Walker2
1The University of Chicago Medicine, Chicago, Illinois.
Journal of the American College of Radiology : JACR
|August 11, 2026
Summary
This study provides guidelines for imaging diffuse lung diseases (DLD), covering initial diagnosis, acute exacerbations, and surveillance. It emphasizes the role of imaging in multidisciplinary discussions for accurate DLD management.
Area of Science:
- Pulmonology
- Radiology
- Medical Imaging
Background:
- Diffuse lung diseases (DLD), also known as diffuse parenchymal or interstitial lung diseases, are a complex group of disorders affecting lung tissue.
- These conditions have varied causes and can involve multiple compartments within the chest.
- Accurate diagnosis and monitoring of DLD are crucial for patient outcomes.
Purpose of the Study:
- To establish evidence-based guidelines for the imaging evaluation of diffuse lung diseases.
- To provide recommendations for initial imaging in suspected DLD cases.
- To guide imaging for acute exacerbations and surveillance in confirmed DLD.
Main Methods:
- The guidelines are developed by a multidisciplinary expert panel, adhering to the American College of Radiology Appropriateness Criteria.
- Methodologies like Grading of Recommendations Assessment, Development, and Evaluation (GRADE) are adapted for evidence evaluation.
- The RAND/UCLA Appropriateness Method guides the determination of imaging procedure appropriateness.
Main Results:
- The document outlines imaging strategies for three key clinical scenarios in DLD management.
- It integrates current literature and expert opinion to formulate recommendations.
- Guidelines address initial diagnosis, acute exacerbations, and routine surveillance of DLD.
Conclusions:
- These guidelines aim to standardize and optimize the use of imaging in the evaluation and management of diffuse lung diseases.
- They support multidisciplinary decision-making for DLD.
- The recommendations are intended to improve diagnostic accuracy and patient care for individuals with DLD.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:23Assessment of Respiration
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...